Amended and Restated INTELLECTUAL PROPERTY LICENSE AGREEMENTIntellectual Property License Agreement • April 9th, 2024 • Lexaria Bioscience Corp. • Pharmaceutical preparations • British Columbia
This Amended and Restated Intellectual Property License Agreement is made and entered as of the 15th day of March, 2024 (the “Effective Date”) by and between Lexaria Hemp Corp., a US corporation with offices at #100 – 740 McCurdy Road, Kelowna, British Columbia, Canada V1X 2P7, Canada (the “LICENSOR”), and Premier Anti-Aging Co., Ltd. a Japanese corporation with offices at Toranomon Hills Station Tower 34F, Toranomon 2-6-1, Minato-ku, Tokyo, Japan, 105-5534 (together with its successors and assigns the “LICENSEE”). LICENSOR and LICENSEE are sometimes referred to individually herein as a “Party” and collectively as the “Parties”.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 9th, 2024 • Lexaria Bioscience Corp. • Pharmaceutical preparations • Florida
WHEREAS LBC serves as the Nasdaq listed parent company of the following subsidiaries: Kelowna Management Services Corp. (“KMSC”), Poviva Corp. (“Poviva”), Lexaria CanPharm ULC (“CanPharm”), Lexaria Nicotine LLC (“Nicotine”), Lexaria Pharmaceutical Corp. (“Pharma”), Lexaria Hemp Corp. (“Hemp”), Lexaria CanPharm Holding Corp. (“Holding”), Lexaria Nutraceutical Corp. (“Nutra”) and such future subsidiary companies of LBC (“FutureCos”). Collectively LBC, KMSC, Poviva, CanPharm, Nicotine, Pharma, Hemp, Holding, Nutra and FutureCos are referred to herein as the “Company”.
